Holen Sie sich die Stockscreener-App
99.16
0.11%
0.11
Handel nachbörslich:
98.10
-1.06
-1.07%
Celcuity Inc Aktie (CELC) Neueste Nachrichten
Why Celcuity Inc. stock is trending among retail tradersQuarterly Profit Review & Verified Technical Trade Signals - Улправда
Fundamentals Check: Does Celcuity Inc. stock trade at a discount to peersMarket Sentiment Summary & Weekly Top Gainers Alerts - Улправда
Aug Sectors: How Celcuity Inc. stock reacts to job market dataJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Улправда
How Investors Are Reacting To Celcuity (CELC) Gedatolisib’s Phase 3 Breast Cancer Data And Safety Profile - Yahoo Finance
Leerink Partners raises Celcuity stock price target to $118 on gedatolisib outlook - Investing.com UK
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation - Yahoo Finance
Top Biotech Stocks To Add to Your WatchlistDecember 12th - MarketBeat
Did Gedatolisib’s Phase 3 PFS and Tolerability Data Just Shift Celcuity’s (CELC) Investment Narrative? - simplywall.st
Celcuity (NASDAQ:CELC) Coverage Initiated by Analysts at Wells Fargo & Company - MarketBeat
Celcuity (CELC) Valuation Check After Paradigm-Shifting VIKTORIA-1 Breast Cancer Data Update - Sahm
Celcuity (NASDAQ:CELC) Hits New 1-Year HighShould You Buy? - MarketBeat
Eventide Asset Management LLC Buys 123,774 Shares of Celcuity, Inc. $CELC - MarketBeat
Wells Fargo Initiates Coverage of Celcuity (CELC) with Overweight Recommendation - Nasdaq
Is CELC Stock Overpriced? - timothysykes.com
RH Posts Strong Q3 Sales, Joins Canopy Growth, Tilray Brands, Frequency Electronics And Other Big Stocks Moving Higher On Friday - Benzinga
Celcuity stock hits all-time high at 109.15 USD By Investing.com - Investing.com Canada
Celcuity stock hits all-time high at 109.15 USD - Investing.com
Wells Fargo Initiates Celcuity With Overweight Rating, $126 Price Target - marketscreener.com
Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review - MSN
Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank - Finviz
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium - The Manila Times
Director Cashes Out: Celcuity Stock Sale Revealed! - TipRanks
Richard Buller Sells 3,000 Shares of Celcuity (NASDAQ:CELC) Stock - MarketBeat
New Highs: How interest rate cuts could boost Celcuity Inc stockWeekly Trade Summary & Safe Entry Zone Identification - BỘ NỘI VỤ
Dir Furcht Acquires 250 Of Celcuity Inc [CELC] - TradingView
Earnings Update: Why Celcuity Inc. stock is trending among retail tradersJuly 2025 Breakouts & Safe Entry Trade Signal Reports - BỘ NỘI VỤ
(CELC) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Celcuity stock rallies on Phase III breast cancer trial progress - MSN
17,848 Shares in Celcuity, Inc. $CELC Purchased by M Holdings Securities Inc. - MarketBeat
Celcuity, Inc. (NASDAQ:CELC) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Celcuity (CELC) Price Target Increased by 11.17% to 108.57 - Nasdaq
Dir Buller Files To Sell 3,000 Of Celcuity Inc [CELC] - TradingView
Celcuity (NASDAQ:CELC) Sets New 1-Year HighShould You Buy? - MarketBeat
Saturn V Capital Management LP Boosts Stock Position in Celcuity, Inc. $CELC - MarketBeat
Geode Capital Management LLC Sells 42,691 Shares of Celcuity, Inc. $CELC - MarketBeat
Could Celcuity Drain The Lifeline Of Tumor Growth With Gedatolisib's Comprehensive Approach? - RTTNews
Aug Reactions: Why Celcuity Inc stock is rated strong buyPortfolio Value Summary & Free Accurate Trade Setup Notifications - BỘ NỘI VỤ
Celcuity stock hits all-time high at 103.23 USD By Investing.com - Investing.com Canada
Celcuity Stock Near All-Time Highs — And This Major Biotech Investor Is Still Jumping In - AOL.com
Is Celcuity Inc. stock a defensive play in 2025Weekly Trend Summary & Stock Portfolio Risk Management - Newser
3 Stocks You’ll Wish You Bought Before 2026 - Investing.com
Celcuity Director Cashes In on Stock Sale! - TipRanks
Celcuity (NASDAQ:CELC) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says - MarketBeat
Aug Swings: Does Celcuity Inc stock trade at a discount to peersWeekly Stock Summary & Long-Term Investment Growth Plans - BỘ NỘI VỤ
Jefferies Maintains Celcuity (CELC) Buy Recommendation - MSN
Celcuity submits gedatolisib new drug application to the FDA - MSN
Is Celcuity Inc. stock a bargain at current levelsEarnings Growth Report & Real-Time Chart Breakout Alerts - Newser
Jefferies raises Celcuity stock price target to $134 on positive trial outlook By Investing.com - Investing.com South Africa
Jefferies raises Celcuity stock price target to $134 on positive trial outlook - Investing.com
Dir Buller Files To Sell 1,100 Of Celcuity Inc [CELC] - TradingView
Is Celcuity Inc a good long term investmentChart Pattern Recognition & Small Budget Capital Growth - earlytimes.in
How to Value Roto Pumps Limited Stock Using DCF AnalysisTechnical Resistance Breaks & Rapid Capital Growth - earlytimes.in
Virtus Investment Advisers LLC Has $100,000 Stock Position in Celcuity, Inc. $CELC - MarketBeat
Celcuity outlines $2.5B–$3B peak revenue potential for gedatolisib amid accelerated launch preparations - MSN
How FDA Real-Time Review for Gedatolisib Has Changed Celcuity’s (CELC) Investment Story - simplywall.st
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results - AOL.com
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge - Yahoo Finance
0.31%
0.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):